Production (Stage)
Core Scientific, Inc.
CORZ
$10.68
-$0.15-1.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.35M | 15.03M | 27.22M | 30.36M | 29.33M |
| Total Other Revenue | 67.18M | 79.90M | 68.14M | 110.74M | 149.96M |
| Total Revenue | 79.53M | 94.93M | 95.35M | 141.10M | 179.29M |
| Cost of Revenue | 71.31M | 85.86M | 90.68M | 99.19M | 101.65M |
| Gross Profit | 8.21M | 9.06M | 4.68M | 41.91M | 77.65M |
| SG&A Expenses | 40.12M | 42.88M | 42.34M | 32.31M | 16.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 10.69M | 805.00K | 206.00K | 1.12M | -543.00K |
| Total Operating Expenses | 122.12M | 134.56M | 136.06M | 134.79M | 118.03M |
| Operating Income | -42.59M | -39.63M | -40.71M | 6.31M | 61.27M |
| Income Before Tax | 580.90M | -265.17M | -455.13M | -804.75M | 210.90M |
| Income Tax Expenses | 205.00K | 375.00K | 134.00K | 144.00K | 206.00K |
| Earnings from Continuing Operations | 580.69M | -265.54M | -455.26M | -804.90M | 210.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 580.69M | -265.54M | -455.26M | -804.90M | 210.69M |
| EBIT | -42.59M | -39.63M | -40.71M | 6.31M | 61.27M |
| EBITDA | -22.86M | -13.59M | -12.02M | 35.79M | 90.26M |
| EPS Basic | 1.44 | -0.60 | -1.17 | -4.51 | 0.91 |
| Normalized Basic EPS | 1.15 | -0.55 | -0.97 | -2.82 | 0.27 |
| EPS Diluted | 1.25 | -0.60 | -1.17 | -4.51 | 0.78 |
| Normalized Diluted EPS | 1.00 | -0.55 | -0.97 | -2.82 | 0.22 |
| Average Basic Shares Outstanding | 315.19M | 306.15M | 292.49M | 178.51M | 230.95M |
| Average Diluted Shares Outstanding | 363.31M | 306.15M | 292.49M | 178.51M | 282.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |